Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Salmon

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Revue Medicale De Liege|April 8, 2021
[Multiple myeloma in an elderly patient with history of breast cancer : the value of multidisciplinary oncogeriatric collaboration]M Legros, A S Bouillon, N Janin, et al.
Transfusion|September 30, 1999
Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantationJ P Salmon, S Michaux, J P Hermanne, et al.
Haematologica|November 6, 2001
Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantationB Sautois, E Baudoux, J P Salmon, et al.
Anticancer Research|May 4, 2005
Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trialC Focan, M P Graas, M Beauduin, et al.
Revue Medicale De Liege|March 8, 2022
[Medulloblastoma : management of a usually pediatric tumour in a young adult]C Chatelain, C Piette, A Bex, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2025
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)L Malorni, S Tyekucheva, A Gombos, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Revue Medicale De Liege|April 8, 2021
[Multiple myeloma in an elderly patient with history of breast cancer : the value of multidisciplinary oncogeriatric collaboration]M Legros, A S Bouillon, N Janin, et al.
Transfusion|September 30, 1999
Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantationJ P Salmon, S Michaux, J P Hermanne, et al.
Haematologica|November 6, 2001
Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantationB Sautois, E Baudoux, J P Salmon, et al.
Anticancer Research|May 4, 2005
Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trialC Focan, M P Graas, M Beauduin, et al.
Revue Medicale De Liege|March 8, 2022
[Medulloblastoma : management of a usually pediatric tumour in a young adult]C Chatelain, C Piette, A Bex, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2025
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)L Malorni, S Tyekucheva, A Gombos, et al.
Pageof 2